Prognostic implications of left artial spontaneous echo contrast in nonvalvular atrial fibrillation

Black, 1991, Left atrial spontaneous echo contrast: a clinical and echocardiographic analysis, J Am Coll Cardiol, 18, 398, 10.1016/0735-1097(91)90592-W Daniel, 1988, Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk, J Am Coll Cardiol, 11, 1204, 10.1016/0735-1097(88)90283-5 Sahn, 1978, Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements, Circulation, 58, 1072, 10.1161/01.CIR.58.6.1072 Hirschfeld, 1975, Echocardiogram in calcified mitral annulus, Am J Cardiol, 36, 354, 10.1016/0002-9149(75)90489-0 Helmcke, 1987, Color Doppler assessment of mitral regurgitation with orthogonal planes, Circulation, 75, 175, 10.1161/01.CIR.75.1.175 Seward, 1988, Transesophageal echocardiography: technique, anatomic correlations, implementation and clinical applications, 63, 649 Beppu, 1985, Smoke-like echo in the left atrial cavity in mitral valve disease: its features and significance, J Am Coll Cardiol, 6, 744, 10.1016/S0735-1097(85)80476-9 Beppu, 1984, Clinical features of intracardiac thrombosis based on echocardiographic observation, Jpn Circ J, 48, 75, 10.1253/jcj.48.75 Karalis, 1991, Recognition and embolic potential of intraaortic atherosclerotic debris, J Am Coll Cardiol, 17, 73, 10.1016/0735-1097(91)90706-F Castello, 1990, Prevalence and clinical implications of atrial spontaneous contrast in patients undergoing transesophageal echocardiography, Am J Cardiol, 65, 1149, 10.1016/0002-9149(90)90330-4 Tsai, 1992, Clinical implications of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation, Am J Cardiol, 70, 327, 10.1016/0002-9149(92)90613-4 Wolf, 1991, Atrial fibrillation as an independent risk factor for stroke: the Framingham Study, Stroke, 22, 983, 10.1161/01.STR.22.8.983 Cairns, 1991, Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy, Circulation, 84, 469, 10.1161/01.CIR.84.2.469 Petersen, 1989, Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study, Lancet, 1, 175, 10.1016/S0140-6736(89)91200-2 1991, Stroke Prevention in Atrial Fibrillation Investigators, 84, 527 Connolly, 1991, Canadian Atrial Fibrillation Anticoagulation (CAFA) study, J Am Coll Cardiol, 18, 349, 10.1016/0735-1097(91)90585-W Ezekowitz, 1992, Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators, N Engl J Med, 227, 1406, 10.1056/NEJM199211123272002 1990, The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators, N Engl J Med, 323, 1505, 10.1056/NEJM199011293232201 Cabin, 1990, Risk for systemic embolization of atrial fibrillation without mitral stenosis, Am J Cardiol, 65, 1112, 10.1016/0002-9149(90)90323-S Flegel, 1989, Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation, Stroke, 20, 1000, 10.1161/01.STR.20.8.1000 Corbalan, 1992, Risk factors for systemic embolism in patients with paroxysmal atrial fibrillation, Am Heart J, 124, 149, 10.1016/0002-8703(92)90933-M 1992, The Stroke Prevention in Atrial Fibrillation Investigators, 116, 1 Petersen, 1990, Risk factors for thromboembolic complications in chronic atrial fibrillation, Arch Intern Med, 150, 819, 10.1001/archinte.1990.00390160077016 1992, The Stroke Prevention in Atrial Fibrillation Investigators, 116, 6 Aronow, 1989, Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation, Am J Cardiol, 63, 366, 10.1016/0002-9149(89)90349-4 Caplan, 1986, Atrial size, atrial fibrillation and stroke, Ann Neurol, 19, 158, 10.1002/ana.410190208 Wiener, 1987, Clinical and echocardiographic correlates of systemic embolization in nonrheumatic atrial fibrillation, Am J Cardiol, 59, 177, 10.1016/S0002-9149(87)80102-9 Olson, 1992, Exclusion of atrial thrombus by transesophageal echocardiography, J Am Soc Echocardiogr, 5, 52, 10.1016/S0894-7317(14)80103-X Tunick, 1994, High risk for vascular events in patients with protruding aortic atheroma: a prospective study, J Am Coll Cardiol, 23, 1085, 10.1016/0735-1097(94)90595-9 Black, 1993, Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation, J Am Coll Cardiol, 21, 451, 10.1016/0735-1097(93)90688-W Erbel, 1986, Detection of spontaneous echocardiographic contrast within the left atrium by transesophageal echocardiography: spontaneous echocardiographic contrast, Clin Cardiol, 9, 245, 10.1002/clc.4960090603 Mahony, 1989, Resolution of spontaneous contrast with platelet disaggregatory therapy (trifluoperazine), Am J Cardiol, 63, 1004, 10.1016/0002-9149(89)90163-X Kannel, 1982, Epidemiologic features of chronic atrial fibrillation: The Framingham Study, N Engl J Med, 306, 1018, 10.1056/NEJM198204293061703 Cameron, 1988, Prevalence and significance of atrial fibrillation in coronary heart disease (CASS Registry), Am J Cardiol, 61, 714, 10.1016/0002-9149(88)91053-3